Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes

Author： Stamey James D.   Natanegara Fanni   Seaman John W.  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.23, Iss.4, 2013-07, pp. : 790-803

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calculation of Tolerance Limits and Sample Size Determination for Clinical Trials with Dichotomous Outcomes

By Zaslavsky Boris G.  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 3, 2007-05 ,pp. : 481-491

Taylor & Francis Ltd

Access to resources Recommend Favorite

Performance and Sample Size Requirements of Bayesian Methods for Binary Outcomes in Fixed-Dose Combination Drug Studies

By Holt Melinda  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 1, 2009-01 ,pp. : 120-132

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination in Superiority Clinical Trials with Multiple Co-Primary Correlated Endpoints

By Sozu Takashi  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 650-668

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination for a Specific Region in a Multiregional Trial

By Ko Feng-Shou  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 4, 2010-07 ,pp. : 870-885

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination for Testing Equality in a Cluster Randomized Trial with Noncompliance

By Lui Kung-Jong  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 1, 2011-01 ,pp. : 1-17

Taylor & Francis Ltd

Access to resources Recommend Favorite